Measuring visual fields with cloud-based AI platform

Video

Dr Mohamed Abou Shousha and Dr Richard Parrish II discuss their ARVO 2021 presentation regarding a study analyzing visual field measurements using the Heru Visual Field Multi-platform application downloaded on two different commercially available augmented reality devices.

Dr Mohamed Abou Shousha and Dr Richard Parrish II both of the University of Miami Health System Bascom Palmer Eye Institute, discuss their ARVO 2021 presentation regarding a study analyzing visual field measurements using the Heru Visual Field Multi-platform application downloaded on two different commercially available augmented reality devices.

Note: Dr Shousha is also CEO and founder of Hero

See more ARVO coverage here

Recent Videos
3 experts are featured in this series.
Vikas Chopra at AAO 2024: Advancements in MIGS are transforming patient care
AAO 2024: Bonnie An Henderson, MD, talks about advancing medical education with AI, robotics, and diverse learning methods
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Professor Shahina Pardhan, BSC, PhD, MBCO, H DHealth Brad, Director of the Vision and Eye Research Institute, School of Medicine, at Anglia Ruskin University in Cambridge, United Kingdom.
Penny A Asbell, MD, FACS speaks at the 2023 AAO meeting
Related Content
A person holds an Ozempic injector pen. Image credit: ©alones – stock.adobe.com

European Medicines Agency will assess semaglutide for link to NAION

Hattie Hayes
December 20th 2024
Article

The Danish Medicines Agency requested the EMA's Pharmacovigilance Risk Assessment Committee review reports on the vision-threatening condition

PHOTON Results and Their Relation to DME Patients in Your Practice

PHOTON Results and Their Relation to DME Patients in Your Practice

July 25th 2024
Podcast

John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.

A doctor looks at a patient's chest x-ray. Image credit: ©Chinnapong – stock.adobe.com

Ocular tuberculosis and relapse rates for recurrence of uveitis

Lynda Charters
November 26th 2024
Article

Uveitic relapses primarily manifest as anterior uveitis, the authors said

PULSAR Results and Their Relation to nAMD Patients in Your Practice

PULSAR Results and Their Relation to nAMD Patients in Your Practice

July 24th 2024
Podcast

John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.

A black box in a dark room is opened slightly. The lid is displaced and a red light glows inside. Image credit: ©alastis – stock.adobe.com

The “black box” of artificial intelligence in ophthalmology

Johan Blanckaert, MD
October 7th 2024
Article

Making the most of AI means letting go of fear, says Editorial Advisory Board member Johan Blanckaert, MD

Pencil on survey paper Image credit: ©zimmytws - adobe.stock.com

Johnson & Johnson Vision supports EC survey on potential electronic Instructions for Use expansion

Jordana Joy
September 19th 2024
Article

Depending on results from the survey for healthcare professionals, a scope expansion for eIFUs could impact ophthalmic devices including contact lenses.

© 2024 MJH Life Sciences

All rights reserved.